{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:28:54Z","timestamp":1781659734232,"version":"3.54.5"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ejim.2020.01.007","type":"journal-article","created":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T18:16:40Z","timestamp":1579630600000},"page":"35-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Light anti-thrombotic regimen after interatrial shunt device closure: A strategy for all patients?"],"prefix":"10.1016","volume":"74","author":[{"given":"Riccardo","family":"Cappato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2020.01.007_bib0001","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1093\/eurheartj\/ehq249","article-title":"ESC guidelines for the management of grown-up congenital heart disease (new version 2010)","volume":"31","author":"Baumgartner","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2020.01.007_bib0002","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1093\/eurheartj\/ehy649","article-title":"European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism","volume":"40","author":"Pristipino","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2020.01.007_bib0003","first-page":"486","article-title":"Thrombosis after septal closure device placement: a review of the current literature","volume":"63","author":"Sherman","year":"2004","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ejim.2020.01.007_bib0004","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.amjcard.2006.05.067","article-title":"Embolic stroke due to a left atrial thrombus two years after placement of an atrial septaldefect closure device","volume":"98","author":"Raghu","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejim.2020.01.007_bib0005","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1080\/17434440.2018.1526674","article-title":"Interatrial shunts: technical approaches to percutaneous closure","volume":"15","author":"Rigatelli","year":"2018","journal-title":"Expert Rev Med Devices"},{"key":"10.1016\/j.ejim.2020.01.007_bib0006","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1067\/mje.2002.121666","article-title":"Transcatheter closure of atrial septal defect and patent foramen ovale in adult patients using the Amplatzer occlusion device: no evidence for thrombus deposition with antiplatelet agents","volume":"15","author":"Brandt","year":"2002","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.ejim.2020.01.007_bib0007","doi-asserted-by":"crossref","first-page":"34","DOI":"10.15420\/icr.2018.33.2","article-title":"Patent foramen oovale closure in 2019","volume":"14","author":"Giblett","year":"2019","journal-title":"Interv Cardiol"},{"key":"10.1016\/j.ejim.2020.01.007_bib0008","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1009639","article-title":"Closure or medical therapy for cryptogenic stroke with patent foramen ovale","volume":"366","author":"Furlan","year":"2012","journal-title":"N Eng J Med"},{"key":"10.1016\/j.ejim.2020.01.007_bib0009","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","article-title":"Closure of patent foramen ovale versus medical therapy after cryptogenic stroke","volume":"368","author":"Carroll","year":"2013","journal-title":"N Eng J Med"},{"key":"10.1016\/j.ejim.2020.01.007_bib0010","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","article-title":"Percutaneous closure of patent foramen ovale in cryptogenic embolism","volume":"368","author":"Meier","year":"2013","journal-title":"N Eng J Med"},{"key":"10.1016\/j.ejim.2020.01.007_bib0011","unstructured":"Rigatelli G, Zuin M, Dell'Avvocata F, Roncon L, Vassilev D, Nghia N. Light anti-thrombotic regimen for prevention of device thrombosis and\/or thrombotic after interatrial shunts device-based closure. European J Int Med, In press (1,147)."}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620520300078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620520300078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:30:58Z","timestamp":1760607058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620520300078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":11,"alternative-id":["S0953620520300078"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2020.01.007","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Light anti-thrombotic regimen after interatrial shunt device closure: A strategy for all patients?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2020.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2019.12.010","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}